Skip to main content
SpringerLink
Log in

Reconstructive Transplantation: Program, Patient, Protocol, Policy, and Payer Considerations

  • Chapter
  • First Online:
Anesthesia and Perioperative Care for Organ Transplantation

Abstract

The goals of reconstructive transplantation are similar to those of reconstructive surgery: to replace and restore missing tissue as functional “whole” subunits. These goals may be achieved with vascularized composite allotransplantation (VCA), which may result in nearly perfect restoration of tissue defects with improved functional and esthetic outcomes while avoiding the multiple surgeries and donor site morbidity associated with conventional reconstruction. This chapter provides an overview of the program-, patient-, provider-, payer-, and policy-related considerations in VCA, with special emphasis and critical appraisal of key aspects.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Shores JT, Brandacher G, Schneeberger S, Gorantla VS, Lee WPA. Composite tissue allotransplantation: hand transplantation and beyond. J Am Acad Orthop Surg. 2010;18(3):127–31.

    Article  PubMed  Google Scholar 

  2. Gorantla V. Composite tissue allotransplantation (CTA): current status and future insights. Eur J Trauma. 2001;27(6): 267–74.

    Article  Google Scholar 

  3. Mohan R, Borsuk DE, Dorafshar AH, et al. Aesthetic and functional facial transplantation: a classification system and treatment algorithm. Plast Reconstr Surg. 2014;133(2):386–97. doi:10.1097/01.prs.0000437259.24069.35.

    Article  CAS  PubMed  Google Scholar 

  4. Gorantla VS, Gonzalez RN, Breidenbach WC III. Hand and composite tissue allotransplantation: past, present, and future. In: The mutilated hand. Elsevier; 2005. p. 591–609. doi: 10.1016/B978-1-56053-446-4.50047-2.

  5. Hautz T, Brandacher G, Engelhardt TO, et al. How reconstructive transplantation is different from organ transplantation—and how it is not. Transplant Proc. 2011;43(9):3504–11. doi:10.1016/j.transproceed.2011.08.044.

    Article  CAS  PubMed  Google Scholar 

  6. Cendales L, Granger D, Henry M, et al. Implementation of vascularized composite allografts in the United States: recommendations from the ASTS VCA Ad Hoc Committee and the Executive Committee. Am J Transplant. 2011;11(1):13–7. doi:10.1111/j.1600-6143.2010.03374.x.

    Article  CAS  PubMed  Google Scholar 

  7. Cendales LC, Xu H, Bacher J, Eckhaus MA, Kleiner DE, Kirk AD. Composite tissue allotransplantation: development of a preclinical model in nonhuman primates. Transplantation. 2005; 80(10):1447.

    Article  PubMed  Google Scholar 

  8. McDiarmid SV, Levin LS, Luskin RS. Vascularized composite tissue allografts (VCA): the policy side. Curr Transpl Rep. 2016;3(1):50–6. doi:10.1007/s40472-016-0094-9.

    Article  Google Scholar 

  9. Ravindra KV, Gorantla VS. Development of an upper extremity transplant program. Hand Clin. 2011;27(4):531–8-x. doi:10.1016/j.hcl.2011.07.008.

    Article  PubMed  Google Scholar 

  10. Amirlak B, Gonzalez R, Gorantla V, Breidenbach WC, Tobin GR. Creating a hand transplant program. Clin Plast Surg. 2007;34(2):279–89-x. doi:10.1016/j.cps.2007.01.002.

    Article  PubMed  Google Scholar 

  11. Hartzell TL, Benhaim P, Imbriglia JE, et al. Surgical and technical aspects of hand transplantation: is it just another replant? Hand Clin. 2011;27(4):521–30–x. doi:10.1016/j.hcl.2011.08.001.

    Article  PubMed  Google Scholar 

  12. Gorantla VS, Schneeberger S, Moore LR, et al. Development and validation of a procedure to isolate viable bone marrow cells from the vertebrae of cadaveric organ donors for composite organ grafting. Cytotherapy. 2012;14(1):104–13. doi:10.3109/14653249.2011.605350.

    Article  CAS  PubMed  Google Scholar 

  13. Donnenberg AD, Gorantla VS, Schneeberger S, et al. Clinical implementation of a procedure to prepare bone marrow cells from cadaveric vertebral bodies. Regen Med. 2011;6(6):701–6. doi:10.2217/rme.11.89.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Schneeberger S, Gorantla VS, Brandacher G. Upper-extremity transplantation using a cell-based protocol to minimize immunosuppression. Ann Surg. 2013;257(2):345–51. doi:10.1097/SLA.0b013e31826d90bb.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Brazio PS, Barth RN, Bojovic B, et al. Algorithm for total face and multiorgan procurement from a brain-dead donor. Am J Transplant. 2013;13(10):2743–9. doi:10.1111/ajt.12382.

    Article  CAS  PubMed  Google Scholar 

  16. Caterson EJ, Diaz-Siso JR, Shetye P, et al. Craniofacial principles in face transplantation. J Craniofac Surg. 2012;23(5):1234–8. doi:10.1097/SCS.0b013e318252d406.

    Article  PubMed  Google Scholar 

  17. Wainwright S. Non-adherence with medications in organ transplant patients: a literature review. J Adv Nurs. 1997;26(5):968–77.

    Article  CAS  PubMed  Google Scholar 

  18. Westvik TS, Dermietzel A, Pomahac B. Facial restoration by transplantation: the Brigham and Women’s face transplant experience. Ann Plast Surg. 2015;74 Suppl 1:S2–8. doi:10.1097/SAP.0000000000000525.

    Article  CAS  PubMed  Google Scholar 

  19. Kueckelhaus M, Lehnhardt M, Fischer S, Eriksson E, Pomahac B, Hirsch T. Progress in face transplantation. Handchir Mikrochir Plast Chir. 2014;46(4):206–13. doi:10.1055/s-0034-1385850.

    Article  CAS  PubMed  Google Scholar 

  20. Livingston E. Primum non nocere. Ann Intern Med. 2011;155(5): 329–30.

    Article  PubMed  Google Scholar 

  21. Gorantla VS, Barker JH, Jones JW, Prabhune K, Maldonado C, Granger DK. Immunosuppressive agents in transplantation: mechanisms of action and current anti-rejection strategies. Microsurgery. 2000;20(8):420–9.

    Article  CAS  PubMed  Google Scholar 

  22. Glances at the history of transplantation immunology. Müller-Ruchholtz W. Transplant Proc. 1999;31(3):1443–51.

    Google Scholar 

  23. Lakkis FG, Sayegh MH. Memory T cells: a hurdle to immunologic tolerance. J Am Soc Nephrol. 2003;14(9):2402–10. doi:10.1097/01.ASN.0000085020.78117.70.

    Article  PubMed  Google Scholar 

  24. Lakkis FG. Transplantation tolerance: a journey from ignorance to memory. Nephrol Dial Transplant. 2003;18(10):1979–82. doi:10.1093/ndt/gfg312.

    Article  CAS  PubMed  Google Scholar 

  25. Lakkis F. Transplantation tolerance. In: Living donor organ transplantation (Softcover edition for special sale). CRC Press; 2013. p. 405–15. doi: 10.1201/b14357-35.

  26. Gorantla VS, Schneeberger S, Brandacher G, et al. T regulatory cells and transplantation tolerance. Transplant Rev (Orlando). 2010;24(3):147–59. doi:10.1016/j.trre.2010.04.002.

    Article  Google Scholar 

  27. Gorantla VS, Brandacher G, Schneeberger S, et al. Favoring the risk-benefit balance for upper extremity transplantation—the Pittsburgh protocol. Hand Clin. 2011;27(4):511–20–ix–x. doi:10.1016/j.hcl.2011.08.008.

    Article  PubMed  Google Scholar 

  28. Calne RY. Current status of clinical transplantation tolerance. Curr Opin Organ Transplant. 2006;11(4):385–8. doi:10.1097/01.mot.0000236701.37587.d4.

    Article  Google Scholar 

  29. Thomson AW, Zahorchak AF, Ezzelarab MB, Butterfield LH, Lakkis FG, Metes DM. Prospective clinical testing of regulatory dendritic cells in organ transplantation. Front Immunol. 2016;7 Suppl 3:1289. doi:10.3389/fimmu.2016.00015.

    Google Scholar 

  30. Plock JA, Schnider JT, Solari MG, Zheng XX, Gorantla VS. Perspectives on the use of mesenchymal stem cells in vascularized composite allotransplantation. Front Immunol. 2013;4:175. doi:10.3389/fimmu.2013.00175.

    PubMed  PubMed Central  Google Scholar 

  31. Wachtman GS, Wimmers EG, Gorantla VS, et al. Biologics and donor bone marrow cells for targeted immunomodulation in vascularized composite allotransplantation: a translational trial in swine. Transplant Proc. 2011;43(9):3541–4. doi:10.1016/j.transproceed.2011.10.010.

    Article  CAS  PubMed  Google Scholar 

  32. Plock JA, Schnider JT, Schweizer R, Gorantla VS. Are cultured mesenchymal stromal cells an option for immunomodulation in transplantation? Front Immunol. 2013;4:41. doi:10.3389/fimmu.2013.00041.

    PubMed  PubMed Central  Google Scholar 

  33. Plock JA, Schnider JT, Zhang W, et al. Adipose- and bone marrow-derived mesenchymal stem cells prolong graft survival in vascularized composite allotransplantation. Transplantation. 2015;99(9): 1765–73. doi:10.1097/TP.0000000000000731.

    Article  CAS  PubMed  Google Scholar 

  34. Schweizer R, Gorantla VS, Plock JA. Premise and promise of mesenchymal stem cell-based therapies in clinical vascularized composite allotransplantation. Curr Opin Organ Transplant. 2015; 20(6):608–14. doi:10.1097/MOT.0000000000000247.

    Article  CAS  PubMed  Google Scholar 

  35. Tsuji W, Schnider JT, McLaughlin MM, et al. Effects of immunosuppressive drugs on viability and susceptibility of adipose- and bone marrow-derived mesenchymal stem cells. Front Immunol. 2015;6:131. doi:10.3389/fimmu.2015.00131.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Ravindra KV, Xu H, Bozulic LD. The need for inducing tolerance in vascularized composite allotransplantation. Clin Dev Immunol. 2012;2012:438078.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Calne R, Watson CJE. Some observations on prope tolerance. Curr Opin Organ Transplant. 2011;16(4):353–8. doi:10.1097/MOT.0b013e328348b44c.

    Article  CAS  PubMed  Google Scholar 

  38. Calne RY. Prope tolerance—the future of organ transplantation from the laboratory to the clinic. Int Immunopharmacol. 2005;5(1):163–7. doi:10.1016/j.intimp.2004.09.026.

    Article  CAS  PubMed  Google Scholar 

  39. Tuffaha S, Quigley M, Ng T, et al. The effect of chondroitinase on nerve regeneration following composite tissue allotransplantation. J Hand Surg. 2011;36(9):1447–52. doi:10.1016/j.jhsa.2011.06.007.

    Article  Google Scholar 

  40. Health Resources Services Administration (HRSA), Department of Health and Human Services (HHS). Organ procurement and transplantation network. Final rule. Fed Regist. 2013;78(128):40033–42.

    Google Scholar 

  41. Cendales LC, Rahmel A, Pruett TL. Allocation of vascularized composite allografts: what is it? Transplantation. 2012;93(11):1086–7. doi:10.1097/TP.0b013e31824b073f.

    Article  PubMed  Google Scholar 

  42. Siemionow M, Gatherwright J, Djohan R, Papay F. Cost analysis of conventional facial reconstruction procedures followed by face transplantation. Am J Transplant. 2011;11(2):379–85. doi:10.1111/j.1600-6143.2010.03373.x.

    Article  CAS  PubMed  Google Scholar 

  43. Nguyen LL, Naunheim MR, Hevelone ND, et al. Cost analysis of conventional face reconstruction versus face transplantation for large tissue defects. Plast Reconstr Surg. 2015;135(1):260–7. doi:10.1097/PRS.0000000000000799.

    Article  CAS  PubMed  Google Scholar 

  44. You Han Bae KP. Targeted drug delivery to tumors: myths, reality and possibility. J Control Release. 2011;153(3):198–205. doi:10.1016/j.jconrel.2011.06.001.

    Article  PubMed  PubMed Central  Google Scholar 

  45. Breidenbach WC, Meister EA, Turker T, Becker GW, Gorantla VS, Levin LS. A methodology for determining standard of care status for a new surgical procedure: hand transplantation. Plast Reconstr Surg. 2016;137(1):367–73. doi:10.1097/PRS.0000000000001892.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Plastic Surgery, Reconstructive Transplant Program, University of Pittsburgh Medical Center, 200 Lothrop Street, Pittsburgh, PA, 15213-2582, USA

    Vijay S. Gorantla M.D., Ph.D.

  2. Department of Plastic Surgery and Hand Surgery, University Hospital Zurich (USZ), Zurich, Switzerland

    Jan A. Plock M.D.

  3. Plastic and Reconstructive Surgery, San Antonio Military Medical Center, United States Army Institute for Surgical Research, Pittsburgh, PA, USA

    Michael R. Davis M.D., F.A.C.S.

Authors
  1. Vijay S. Gorantla M.D., Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jan A. Plock M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Michael R. Davis M.D., F.A.C.S.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Vijay S. Gorantla M.D., Ph.D. .

Editor information

Editors and Affiliations

  1. Department of Anesthesiology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA

    Kathirvel Subramaniam

  2. Department of Anesthesiology The Clinical and Translational Science Institute The McGowan Institute for Regenerative Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA

    Tetsuro Sakai

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer Science+Business Media New York

About this chapter

Cite this chapter

Gorantla, V.S., Plock, J.A., Davis, M.R. (2017). Reconstructive Transplantation: Program, Patient, Protocol, Policy, and Payer Considerations. In: Subramaniam, K., Sakai, T. (eds) Anesthesia and Perioperative Care for Organ Transplantation. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-6377-5_45

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-6377-5_45

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4939-6375-1

  • Online ISBN: 978-1-4939-6377-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation